- Home
- DOMH
as 11-21-2024 4:00pm EST
Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company's oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia.
| Founded: | 1967 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 12.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 11.9K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.81 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.50 - $3.20 | Next Earning Date: | 11-08-2024 |
| Revenue: | $12,589,000 | Revenue Growth: | 1117.50% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Dominari Holdings Inc. News
DOMH Breaking Stock News: Dive into DOMH Ticker-Specific Updates for Smart Investing
ACCESSWIRE
11 days ago
Dominari Holdings Inc. Strengthens Team with Appointment of Experienced Accounting Team
Simply Wall St.
12 days ago
Dominari Holdings Third Quarter 2024 Earnings: US$0.67 loss per share (vs US$0.66 loss in 3Q 2023)
ACCESSWIRE
2 months ago
Dominari Securities LLC Announces Appointment of Capital Markets Veteran James Hopkins as Managing Director Head of Capital Markets
ACCESSWIRE
3 months ago
Dominari Securities LLC Receives Milestone Approval as a Nasdaq Limited Underwriting Member
Simply Wall St.
3 months ago
Several Insiders Invested In Dominari Holdings Flagging Positive News
ACCESSWIRE
7 months ago
Dominari Securities LLC Continues Expansion of Its Capital Market Group with Senior Hires
Insider Monkey
7 months ago
10 Micro-Cap Healthcare Stocks Insiders Are Buying
PR Newswire
8 months ago
Dominari Securities Appoints 30 Year Financial Industry Expert to Manage Operations and Compliance
Compare DOMH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DOMH Dominari Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.